Circadian rhythms measured by actigraphy during oncological treatments: a systematic review

References

• Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. 2003. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 26:342–392.
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, Dimsdale J, Cohen-Zion M, Fiorentino L. 2006. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 14:201–209.10.1007/s00520-005-0861-0
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S, Liu L, Rissling M, Natarajan L, Neikrug AB, Palmer BW, Mills PJ, Parker BA, Sadler GR, Maglione J. 2014. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study. Support Care Cancer. 22:2535–2545.10.1007/s00520-014-2204-5
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, Hery C, Heanue M. 2010. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ. 341:c3620.10.1136/bmj.c3620
   PubMed Web of Science ®Google Scholar
• Berger AM. 1998. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum. 25:51–62.
   PubMedGoogle Scholar
• Berger AM, Grem JL, Visovsky C, Marunda HA, Yurkovich JM. 2010. Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer. Oncol Nurs Forum. 37:E359–E369.10.1188/10.ONF.E359-E369
   Google Scholar
• Berger AM, Higginbotham P. 2000. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol Nurs Forum. 27:1443–1448.
   PubMedGoogle Scholar
• Berger AM, Kuhn BR, Farr LA, Lynch JC, Agrawal S, Chamberlain J, Von Essen SG. 2009. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psychooncology. 18:634–646.10.1002/pon.v18:6
   PubMed Web of Science ®Google Scholar
• Berger AM, Kuhn BR, Farr LA, Von Essen SG, Chamberlain J, Lynch JC, Agrawal S. 2009. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J Clin Oncol. 27:6033–6040.10.1200/JCO.2008.20.8306
   PubMed Web of Science ®Google Scholar
• Berger AM, Treat Marunda HA, Agrawal S. 2009. Influence of menopausal status on sleep and hot flashes throughout breast cancer adjuvant chemotherapy. J Obstet Gynecol Neonatal Nurs. 38:353–366.10.1111/jogn.2009.38.issue-3
   PubMed Web of Science ®Google Scholar
• Berger AM, Wielgus K, Hertzog M, Fischer P, Farr L. 2010. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer. 18:105–114.10.1007/s00520-009-0636-0
   PubMed Web of Science ®Google Scholar
• Berger AM, Wielgus KK, Young-McCaughan S, Fischer P, Farr L, Lee KA. 2008. Methodological challenges when using actigraphy in research. J Pain Symptom Manage. 36:191–199.10.1016/j.jpainsymman.2007.10.008
   PubMed Web of Science ®Google Scholar
• Bonmati-Carrion MA, Middleton B, Revell V, Skene DJ, Rol MA, Madrid JA. 2014. Circadian phase assessment by ambulatory monitoring in humans: correlation with dim light melatonin onset. Chronobiol Int. 31:37–51.10.3109/07420528.2013.820740
   PubMed Web of Science ®Google Scholar
• Brown AC, Smolensky MH, D’Alonzo GE, Redman DP. 1990. Actigraphy: a means of assessing circadian patterns in human activity. Chronobiol Int. 7:125–133.10.3109/07420529009056964
   PubMed Web of Science ®Google Scholar
• Challet E. 2013. Circadian clocks, food intake, and metabolism. Prog Mol Biol Transl Sci. 119:105–135.10.1016/B978-0-12-396971-2.00005-1
   PubMed Web of Science ®Google Scholar
• Cole RJ, Kripke DF, Gruen W, Mullaney DJ, Gillin JC. 1992. Automatic sleep/wake identification from wrist activity. Sleep. 15:461–469.
   PubMed Web of Science ®Google Scholar
• Davis S, Mirick DK, Stevens RG. 2001. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 93:1557–1562.10.1093/jnci/93.20.1557
   PubMed Web of Science ®Google Scholar
• Dodd MJ, Cho MH, Cooper BA, Miaskowski C. 2010. The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs. 14:101–110.10.1016/j.ejon.2009.09.005
   PubMed Web of Science ®Google Scholar
• Donovan KA, Jacobsen PB. 2007. Fatigue, depression, and insomnia: evidence for a symptom cluster in cancer. Semin Oncol Nurs. 23:127–135.10.1016/j.soncn.2007.01.004
   PubMedGoogle Scholar
• Downs SH, Black N. 1998. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Commun Health. 52:377–384.10.1136/jech.52.6.377
   PubMed Web of Science ®Google Scholar
• Du-Quiton J, Wood PA, Burch JB, Grutsch JF, Gupta D, Tyer K, Lis CG, Levin RD, Quiton DF, Reynolds JL, Hrushesky WJ. 2010. Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psychooncology. 19:180–189.10.1002/pon.v19:2
   PubMed Web of Science ®Google Scholar
• Farr L, Boen L. 1996. Comparison of rectal and axillary temperature rhythms with activity. In: Lincoln NB. NASA Space Grant Consortium Symposium. Proceedings of the Nebraska Academy of Sciences. Lincoln, NE. p. 29.
   Google Scholar
• Fernandes R, Stone P, Andrews P, Morgan R, Sharma S. 2006. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. J Pain Symptom Manage. 32:245–254.10.1016/j.jpainsymman.2006.03.014
   PubMed Web of Science ®Google Scholar
• Filipski E, Delaunay F, King VM, Wu MW, Claustrat B, Grechez-Cassiau A, Guettier C, Hastings MH, Francis L. 2004. Effects of chronic jet lag on tumor progression in mice. Cancer Res. 64:7879–7885.10.1158/0008-5472.CAN-04-0674
   PubMed Web of Science ®Google Scholar
• Filipski E, King VM, Li X, Granda TG, Mormont MC, Liu X, Claustrat B, Hastings MH, Levi F. 2002. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst. 94:690–697.10.1093/jnci/94.9.690
   PubMed Web of Science ®Google Scholar
• Filipski E, King VM, Li X, Granda TG, Mormont MC, Claustrat B, Hastings MH, Lévi F. 2003. Disruption of circadian coordination accelerates malignant growth in mice. Pathol Biol. 51:216–219.10.1016/S0369-8114(03)00034-8
   PubMed Web of Science ®Google Scholar
• Filipski E, Levi F. 2009. Circadian disruption in experimental cancer processes. Integr Cancer Ther. 8:298–302.10.1177/1534735409352085
   PubMed Web of Science ®Google Scholar
• Giacchetti S, Bjarnason G, Garufi C, Genet D, Iacobelli S, Tampellini M, Smaaland R, Focan C, Coudert B, Humblet Y, et al. 2006. Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group. J Clin Oncol. 24:3562–3569.10.1200/JCO.2006.06.1440
   PubMed Web of Science ®Google Scholar
• Gondos A, Holleczek B, Janssen-Heijnen M, Brewster DH, Bray F, Rosso S, Hakulinen T, Brenner H. 2009. Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation. Int J Cancer. 125:2666–2672.10.1002/ijc.v125:11
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CG, Grutsch JF. 2007. The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage. 34:40–47.10.1016/j.jpainsymman.2006.10.012
   PubMed Web of Science ®Google Scholar
• Hanisch LJ, Gehrman PR. 2011. Circadian rhythm of hot flashes and activity levels among prostate cancer patients on androgen deprivation therapy. Aging Male. 14:243–248.10.3109/13685538.2011.582528
   PubMed Web of Science ®Google Scholar
• Hanisch LJ, Gooneratne NS, Soin K, Gehrman PR, Vaughn DJ, Coyne JC. 2011. Sleep and daily functioning during androgen deprivation therapy for prostate cancer. Eur J Cancer Care. 20:549–554.10.1111/ecc.2011.20.issue-4
   PubMed Web of Science ®Google Scholar
• Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. 2007. Cancer-related fatigue: the scale of the problem. Oncologist. 12:4–10.10.1634/theoncologist.12-S1-4
   PubMed Web of Science ®Google Scholar
• Innominato PF, Focan C, Gorlia T, Moreau T, Garufi C, Waterhouse J, Giacchetti S, Coudert B, Iacobelli S, Genet D, et al. 2009. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 69:4700–4707.10.1158/0008-5472.CAN-08-4747
   PubMed Web of Science ®Google Scholar
• Innominato PF, Giacchetti S, Bjarnason GA, Focan C, Garufi C, Coudert B, Iacobelli S, Tampellini M, Durando X, Mormont MC, Waterhouse J, Lévi FA. 2012. Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer. Int J Cancer. 131:2684–2692.10.1002/ijc.v131.11
   PubMed Web of Science ®Google Scholar
• Innominato PF, Mormont MC, Rich TA, Waterhouse J, Levi FA, Bjarnason GA. 2009. Circadian disruption, fatigue, and anorexia clustering in advanced cancer patients: implications for innovative therapeutic approaches. Integr Cancer Ther. 8:361–370.10.1177/1534735409355293
   PubMed Web of Science ®Google Scholar
• Innominato PF, Roche VP, Palesh OG, Ulusakarya A, Spiegel D, Lévi FA. 2014. The circadian timing system in clinical oncology. Ann Med. 46:191–207.10.3109/07853890.2014.916990
   PubMed Web of Science ®Google Scholar
• Jim HS, Small B, Faul LA, Franzen J, Apte S, Jacobsen PB. 2011. Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes. Ann Behav Med. 42:321–333.10.1007/s12160-011-9294-9
   PubMed Web of Science ®Google Scholar
• Kapsimalis F, Richardson G, Opp MR, Kryger M. 2005. Cytokines and normal sleep. Curr Opin Pulm Med. 11:481–484.10.1097/01.mcp.0000183062.98665.6b
   PubMed Web of Science ®Google Scholar
• Kirkova J, Aktas A, Walsh D, Davis MP. 2011. Cancer symptom clusters: clinical and research methodology. J Palliat Med. 14:1149–1166.10.1089/jpm.2010.0507
   PubMed Web of Science ®Google Scholar
• Kowalska E, Brown SA. 2007. Peripheral clocks: keeping up with the master clock. Cold Spring Harb Symp Quant Biol. 72:301–305.10.1101/sqb.2007.72.014
   PubMedGoogle Scholar
• Kramer A, Yang FC, Snodgrass P, Li X, Scammell TE, Davis FC, Weitz CJ. 2003. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signalling. Novartis Found Symp. 253:250–266; discussion 102-9, 263-6, 281-4.10.1002/SERIES1767
   PubMedGoogle Scholar
• Larson SJ, Dunn AJ. 2001. Behavioral effects of cytokines. Brain Behav Immun. 15:371–387.10.1006/brbi.2001.0643
   PubMed Web of Science ®Google Scholar
• Leone MJ, Marpegan L, Duhart JM, Golombek DA. 2012. Role of proinflammatory cytokines on lipopolysaccharide-induced phase shifts in locomotor activity circadian rhythm. Chronobiol Int. 29:715–723.10.3109/07420528.2012.682681
   PubMed Web of Science ®Google Scholar
• Lévi F, Dugué PA, Innominato P, Karaboué A, Dispersyn G, Parganiha A, Giacchetti S, Moreau T, Focan C, Waterhouse J, Spiegel D, et al. 2014. Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival. Chronobiol Int. 31:891–900.10.3109/07420528.2014.924523
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 62:e1–e34.10.1016/j.jclinepi.2009.06.006
   PubMed Web of Science ®Google Scholar
• Littner M, Kushida CA, Anderson WM, Bailey D, Berry RB, Davila DG, Hirshkowitz M, Kapen S, Kramer M, Loube D, et al. 2003. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep. 26:337–341.
   PubMed Web of Science ®Google Scholar
• Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR, Dimsdale JE, Rissling M, He F, Ancoli-Israel S. 2009. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology. 18:187–194.10.1002/pon.v18:2
   PubMed Web of Science ®Google Scholar
• Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S. 2012. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun. 26:706–713.10.1016/j.bbi.2012.02.001
   PubMed Web of Science ®Google Scholar
• Liu L, Rissling M, Natarajan L, Fiorentino L, Mills PJ, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S. 2012. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep. 35:237–245.
   PubMed Web of Science ®Google Scholar
• Liu L, Rissling M, Neikrug A, Fiorentino L, Natarajan L, Faierman M, Sadler GR, Dimsdale JE, Mills PJ, Parker BA, Ancoli-Israel S. 2013. Fatigue and circadian activity rhythms in breast cancer patients before and after chemotherapy: a controlled study. Fatigue. 1:12–26.
   PubMedGoogle Scholar
• Lowrey PL, Takahashi JS. 2011. Genetics of circadian rhythms in Mammalian model organisms. Adv Genet. 74:175–230.10.1016/B978-0-12-387690-4.00006-4
   PubMed Web of Science ®Google Scholar
• Miaskowski C, Cooper BA, Paul SM, Dodd M, Lee K, Aouizerat BE, West C, Cho M, Bank A. 2006. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum. 33:E79–E89.10.1188/06.ONF.E79-E89
   PubMedGoogle Scholar
• Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. 2008. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 26:971–982.10.1200/JCO.2007.10.7805
   PubMed Web of Science ®Google Scholar
• Mills PJ, Ancoli-Israel S, Parker B, Natarajan L, Hong S, Jain S, Sadler GR, Känel R. 2008. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. Brain Behav Immun. 22:98–104.10.1016/j.bbi.2007.07.001
   PubMed Web of Science ®Google Scholar
• Morrow GR, Andrews PL, Hickok JT, Roscoe JA, Matteson S. 2002. Fatigue associated with cancer and its treatment. Support Care Cancer. 10:389–398.10.1007/s005200100293
   PubMed Web of Science ®Google Scholar
• Munir F, Yarker J, McDermott H. 2009. Employment and the common cancers: correlates of work ability during or following cancer treatment. Occup Med. 59:381–389.10.1093/occmed/kqp088
   Google Scholar
• Neikrug AB, Rissling M, Trofimenko V, Liu L, Natarajan L, Lawton S, Parker BA, Ancoli-Israel S. 2012. Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med. 10:202–216.10.1080/15402002.2011.634940
   PubMed Web of Science ®Google Scholar
• Opp MR. 2005. Cytokines and sleep. Sleep Med Rev. 9:355–364.10.1016/j.smrv.2005.01.002
   PubMed Web of Science ®Google Scholar
• Ortiz-Tudela E, Iurisci I, Beau J, Karaboue A, Moreau T, Rol MA, Madrid JA, Lévi F, Innominato PF. 2014. The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy. Int J Cancer. 134:2717–2725.10.1002/ijc.28587
   PubMed Web of Science ®Google Scholar
• Ortiz-Tudela E, Martinez-Nicolas A, Campos M, Rol MA, Madrid JA. 2010. A new integrated variable based on thermometry, actimetry and body position (TAP) to evaluate circadian system status in humans. PLoS Comput Biol. 6:e1000996.10.1371/journal.pcbi.1000996
   PubMed Web of Science ®Google Scholar
• Paladino N, Mul Fedele ML, Duhart JM, Marpegan L, Golombek DA. 2014. Modulation of mammalian circadian rhythms by tumor necrosis factor-α. Chronobiol Int. 31:668–679.10.3109/07420528.2014.886588
   PubMed Web of Science ®Google Scholar
• Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR. 2010. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 28:292–298.10.1200/JCO.2009.22.5011
   PubMed Web of Science ®Google Scholar
• Pati AK, Parganiha A, Kar A, Soni R, Roy S, Choudhary V. 2007. Alterations of the characteristics of the circadian rest – activity rhythm of cancer in – patients. Chronobiol Int. 24:1179–1197.10.1080/07420520701800868
   PubMed Web of Science ®Google Scholar
• Redeker NS, Lev EL, Ruggiero J. 2000. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract. 14:275–290; discussion 291-8.
   PubMedGoogle Scholar
• Reppert SM, Weaver DR. 2002. Coordination of circadian timing in mammals. Nature. 418:935–941.10.1038/nature00965
   PubMed Web of Science ®Google Scholar
• Rich T, Innominato PF, Boerner J, Mormont MC, Iacobelli S, Baron B, Jasmin C, Levi F. 2005. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res. 11:1757–1764.10.1158/1078-0432.CCR-04-2000
   PubMed Web of Science ®Google Scholar
• Roche VP, Mohamad-Djafari A, Innominato PF, Karaboué A, Gorbach A, Lévi FA. 2014. Thoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapy. Chronobiol Int. 31:409–420.10.3109/07420528.2013.864301
   PubMed Web of Science ®Google Scholar
• Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, Smailyte G, Ponti A, Brewster DH, Voogd AC, et al. 2010. Up-to-date estimates of breast cancer survival for the years 2000–2004 in 11 European countries: the role of screening and a comparison with data from the United States. Eur J Cancer. 46:3351–3357.10.1016/j.ejca.2010.09.019
   PubMed Web of Science ®Google Scholar
• Sandadi S, Frasure HE, Broderick MJ, Waggoner SE, Miller JA, von Gruenigen VE. 2011. The effect of sleep disturbance on quality of life in women with ovarian cancer. Gynecol Oncol. 123:351–355.10.1016/j.ygyno.2011.07.028
   PubMed Web of Science ®Google Scholar
• Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, Dimsdale JE, Mills PJ, Parker BA, Sadler GR, Ancoli-Israel S. 2009. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 32:1155–1160.
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA. 2001. Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst. 93:1563–1568.10.1093/jnci/93.20.1563
   PubMed Web of Science ®Google Scholar
• Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE. 2007. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun. 21:413–427.10.1016/j.bbi.2006.11.004
   PubMed Web of Science ®Google Scholar
• Scully CG, Karaboue A, Liu WM, Meyer J, Innominato PF, Chon KH, Gorbach AM, Levi F. 2011. Skin surface temperature rhythms as potential circadian biomarkers for personalized chronotherapeutics in cancer patients. Interface Focus. 1:48–60.10.1098/rsfs.2010.0012
   PubMed Web of Science ®Google Scholar
• Turnbull AV, Rivier CL. 1999. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev. 79:1–71.
   PubMed Web of Science ®Google Scholar